These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 4041376)

  • 1. Characterization of an occult inhibitor to factor IX in a haemophilia B patient.
    Miller CH; Orstavik KH; Hilgartner MW
    Br J Haematol; 1985 Oct; 61(2):329-38. PubMed ID: 4041376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disappearance of inhibitor to factor IX in a patient with severe haemophilia B and immunological characterization of the inhibitor.
    Ohkubo Y; Takahashi Y; Sugimoto M; Nishino M; Nishimura T; Yoshioka A; Fukui H
    Clin Lab Haematol; 1988; 10(2):177-85. PubMed ID: 2843318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IgG subclass identification of inhibitors to factor IX in haemophilia B patients.
    Orstavik KH; Miller CH
    Br J Haematol; 1988 Apr; 68(4):451-4. PubMed ID: 3377985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human factor IX inhibitors: immunochemical characteristics and treatment with activated concentrate.
    Giddings JC; Bloom AL; Kelly MA; Spratt HC
    Clin Lab Haematol; 1983; 5(2):165-75. PubMed ID: 6603957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunological heterogeneity of haemophilia B: a multicentre study of 98 kindreds.
    Parekh VR; Mannucci PM; Ruggeri ZM
    Br J Haematol; 1978 Dec; 40(4):643-55. PubMed ID: 103564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alloantibodies to factor IX in Haemophilia B characterized by crossed immunoelectrophoresis and enzyme-conjugated antisera to human immunoglobulins.
    Orstavik KH
    Br J Haematol; 1981 May; 48(1):15-23. PubMed ID: 6788066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haemophilia B+ with inhibitor.
    Ludwig M; Schwaab R; Olek K; Brackmann HH; Egli H
    Thromb Haemost; 1988 Apr; 59(2):340. PubMed ID: 3388303
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibitor incidence in previously untreated patients with severe haemophilia B: a systematic literature review.
    Franchini M; Santoro C; Coppola A
    Thromb Haemost; 2016 Jul; 116(1):201-3. PubMed ID: 27052668
    [No Abstract]   [Full Text] [Related]  

  • 9. Sensitive solid phase enzyme immunoassay for factor IX antigen and classification of hemophilia B.
    Takamatsu J; Kamiya T; Ogata K; Sugihara T; Koie K; Kato K
    Haemostasis; 1983; 13(1):9-16. PubMed ID: 6341181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spontaneous disappearance of an IgA anti-factor IX inhibitor in a child with Christmas disease.
    Carroll RR; Panush RS; Kitchens CS
    Am J Hematol; 1984 Oct; 17(3):321-5. PubMed ID: 6475941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of factor IX inhibitors by immunoradiometric assay.
    Ljung R; Holmberg L
    Acta Haematol; 1983; 70(5):307-11. PubMed ID: 6414224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of carriers of haemophilia B.
    Orstavik KH; Veltkamp JJ; Bertina RM; Hermans J
    Br J Haematol; 1979 Jun; 42(2):293-301. PubMed ID: 465373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of factor IX inhibitor development in severe haemophilia B patients treated with only one brand of high purity plasma derived factor IX concentrate.
    Parquet A; Laurian Y; Rothschild C; Navarro R; Guérois C; Gay V; Durin A; Peynet J; Sultan Y
    Thromb Haemost; 1999 Oct; 82(4):1247-9. PubMed ID: 10544907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of split tolerance and clinical cure in high-responding hemophiliacs with factor IX antibodies.
    Nilsson IM; Berntorp E; Zettervall O
    Proc Natl Acad Sci U S A; 1986 Dec; 83(23):9169-73. PubMed ID: 3491368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of heterogeneity of haemophilia B for the detection of carriers.
    Panicucci F; Sagripanti A; Conte B; Pinori E; Vispi M; Lecchini L
    Haemostasis; 1980; 9(5):310-8. PubMed ID: 6157611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factor IX alloantibodies shorten the bovine thromboplastin coagulation time of normal human plasma.
    Orstavik KH
    Thromb Haemost; 1981 Dec; 46(4):684-6. PubMed ID: 7330818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on immunological assay of vitamin-K dependent factors. III. A double monoclonal immunoradiometric assay for factor IX antigen.
    Mikami S; O'Brien DP; Mellars G; Goodall AH; Tuddenham EG
    Br J Haematol; 1986 Mar; 62(3):513-24. PubMed ID: 3485443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitors in congenital coagulation disorders.
    Key NS
    Br J Haematol; 2004 Nov; 127(4):379-91. PubMed ID: 15521914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An agarose plate method for detecting alloantisera to coagulant factor IX and factor IX antigen.
    Reisner HM; Strand EA; Chung KS; Roberts HR
    Br J Haematol; 1980 Feb; 44(2):313-21. PubMed ID: 7378302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of secondary antibody response by intravenous immunoglobulin and development of tolerance in a patient with haemophilia B and antibodies.
    Nilsson IM; Sundqvist SB
    Scand J Haematol Suppl; 1984; 40():203-6. PubMed ID: 6591389
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.